Cargando…
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
• COVID-19 is associated with specific skin manifestations and drug eruption. • This case shows COVID-19–related drug eruption and specific clinical features. • Drug eruption preceding COVID-19 symptoms may facilitate early diagnosis.
Autores principales: | Sakaida, Takashi, Tanimoto, Isao, Matsubara, Akihiro, Nakamura, Motoki, Morita, Akimichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229941/ https://www.ncbi.nlm.nih.gov/pubmed/32425356 http://dx.doi.org/10.1016/j.jdermsci.2020.05.002 |
Ejemplares similares
-
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
por: Matsubara, Akihiro, et al.
Publicado: (2021) -
Follicular eruption as a cutaneous manifestation in COVID-19
por: Danarti, Retno, et al.
Publicado: (2020) -
Tertiary Lymphoid Structures and Chemokine Landscape in Virus-Positive and Virus-Negative Merkel Cell Carcinoma
por: Nakamura, Motoki, et al.
Publicado: (2022) -
Effectiveness of combined low-dose radiotherapy and pazopanib for controlling the local manifestations of taxane-resistant recurrent angiosarcoma of the head
por: Kato, Hiroshi, et al.
Publicado: (2020) -
Eruption as a clinical manifestation of COVID-19: photographs of a patient()
por: Hoenig, Leonard J., et al.
Publicado: (2020)